SDS

Page 8/11
Safety Data Sheet
according to 1272/2008/EC (CLP) and OSHA GHS
Revision: June 18, 2015
Trade name: Super Lube® Syncopen® Synthetic Penetrant
(Contd. of page 7)
40.1.3
SECTION 11: Toxicological information
·
11.1 Information on toxicological effects
·
Acute toxicity:
·
LD/LC50 values relevant for classification:
64742-47-8 Distillates (petroleum), hydrotreated light
Oral LD50 > 5000 mg/kg (rat)
·
Primary irritant effect:
·
on the skin:
No irritant effect.
·
on the eye:
Slight irritant effect on eyes.
·
Additional toxicological information:
At long or repeated contact with skin it may cause dermatitis due to the degreasing effect of the solvent.
The product shows the following dangers according to the calculation method of the General EU
Classification Guidelines for Preparations as issued in the latest version:
·
Acute effects (acute toxicity, irritation and corrosivity):
May be fatal if swallowed and enters airways.
May be harmful if swallowed.
·
Repeated dose toxicity:
Repeated exposure may cause skin dryness or cracking.
May cause damage to organs through prolonged or repeated exposure.
SECTION 12: Ecological information
·
12.1 Toxicity
·
Aquatic toxicity:
No further relevant information available.
·
12.2 Persistence and degradability
No further relevant information available.
·
12.3 Bioaccumulative potential
No further relevant information available.
·
12.4 Mobility in soil
No further relevant information available.
·
Ecotoxical effects:
·
Remark:
Due to mechanical actions of the product (e.g. agglutinations) damages may occur.
The product is oxygen-consuming. The declared action may be partly caused by lack of oxygen.
·
Additional ecological information:
·
General notes:
This statement was deduced from the properties of the single components.
Water hazard class 1 (German Regulation) (Self-assessment): slightly hazardous for water
Do not allow undiluted product or large quantities of it to reach ground water, water course or sewage
system.
·
12.5 Results of PBT and vPvB assessment
·
PBT:
Not applicable.
·
vPvB:
Not applicable.
·
12.6 Other adverse effects
No further relevant information available.
(Contd. on page 9)